A Phase Ib Dose-Escalation and Expansion Study of the BCL2 Inhibitor Venetoclax Combined with Tamoxifen in ER and BCL2-Positive Metastatic Breast Cancer Journal Articles Refereed uri icon

Overview

Published in

  • Cancer Discovery

Time

Date/time value

  • 2019

Identity

Digital Object Identifier (DOI)

  • 10.1158/2159-8290.CD-18-1151

Additional Document Info

Parent Title

  • CANCER DISCOVERY

Volume

  • 9

Issue

  • 3

Publisher

  • American Association for Cancer Research